Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Izba (Travoprost 0.003%) vs Travatan in Glaucoma or Ocular Hypertension
NCT01453855Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2011
- Primary completion
- Aug 2012
01
Overview
A Phase 3 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Nov 2011; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01453855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453855.